Satoshi Watanabe

14PUBLICATIONS

49CO-AUTHORS

Molecular targetsMedical infection agents (incl. prions)Medical mycologyInnate immunityMechanobiology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|Jul 02, 2026

Amphiregulin-mediated EGFR activation drives both intrinsic and acquired resistance to KRAS G12C inhibitors in KRAS G12C-mutant non-small cell lung cancer.

|Dec 19, 2025

Influenza A infection accelerates disease-associated microglia formation during physiological aging.

Rogan A Grant, Constance E Runyan, Grace A Minogue

|Jun 04, 2024

The lung as a site for the generation of anti-MDA5 antibody in clinically amyopathic dermatomyositis.

Ryo Hara, Satoshi Watanabe, Nanao Terada

|Oct 21, 2023

Absence of interstitial lung disease at initial visit may predict a favorable outcome for Japanese patients with systemic sclerosis with anti-topoisomerase I antibody.

Yasuhito Hamaguchi, Yukari Yoshimura, Motoki Horii

|Feb 24, 2022

Lung Injury Induces Alveolar Type 2 Cell Hypertrophy and Polyploidy with Implications for Repair and Regeneration.

Anthea Weng, Mariana Maciel Herrerias, Satoshi Watanabe

|Dec 03, 2021

Bronchial Cast Hiding Pulmonary Tuberculosis.

Takahiro Shimizu, Satoshi Watanabe, Akari Murata

Pageof 3

Frequent Collaborators

G R Scott Budinger

Alexander V Misharin

Rogan A Grant

Constance E Runyan

Lynn C Welch

Hiam Abdala-Valencia

Nikita Joshi

Ziyan Lu

Nikolay S Markov

Jacob I Sznajder

Frequent Collaborators

G R Scott Budinger

Alexander V Misharin

Rogan A Grant

Constance E Runyan